Heparan sulfate degradation in tumor cell invasion and angiogenesis.
Vlodavsky
I
I
Department of Oncology and Hematology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
Eldor
A
A
Bar-Ner
M
M
Fridman
R
R
Cohen
I R
IR
Klagsbrun
M
M
D000818:Animals; D005966:Glucuronidase; D006025:Glycosaminoglycans / Q000378:metabolism*; D006026:Glycoside Hydrolases / Q000378:metabolism*; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic; D010960:Plasminogen Activators / Q000378:metabolism; D013601:T-Lymphocytes / Q000201:enzymology; D000099175:Heparanase
D005966:Glucuronidase; D006025:Glycosaminoglycans; D006026:Glycoside Hydrolases; D006497:Heparan Sulfate; D010960:Plasminogen Activators; D000099175:Heparanase